Arrowhead Stock Future Price Prediction

ARWR
 Stock
  

USD 33.28  0.68  2.00%   

Arrowhead Pharma stock price prediction is an act of determining the future value of Arrowhead Pharma shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Arrowhead Pharma's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Arrowhead Pharma and does not consider all of the tangible or intangible factors available from Arrowhead Pharma's fundamental data. We analyze noise-free headlines and recent hype associated with Arrowhead Pharma, which may create opportunities for some arbitrage if properly timed.
Please continue to Arrowhead Pharma Basic Forecasting Models to cross-verify your projections.
  
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Arrowhead Pharma based on different types of headlines from major news networks to social media. The Arrowhead stock price prediction module provides an analysis of price elasticity to changes in media outlook on Arrowhead Pharma over a specific investment horizon.Using Arrowhead Pharma hype-based prediction, you can estimate the value of Arrowhead Pharma from the perspective of Arrowhead Pharma response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Arrowhead Pharma using Arrowhead Pharma's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Arrowhead using crowd psychology based on the activity and movement of Arrowhead Pharma's stock price.

Arrowhead Pharma Implied Volatility

    
  58.16  
Arrowhead Pharma's implied volatility exposes the market's sentiment of Arrowhead Pharma stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Arrowhead Pharma's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Arrowhead Pharma stock will not fluctuate a lot when Arrowhead Pharma's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Arrowhead Pharma. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Arrowhead Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Arrowhead because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Arrowhead Pharma after-hype prediction price

    
  $ 33.24  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.

Prediction based on Rule 16 of the current Arrowhead contract

Based on the Rule 16, the options market is currently suggesting that Arrowhead Pharma will have an average daily up or down price movement of about 3.64% per day over the life of the 2022-10-21 option contract. With Arrowhead Pharma trading at $33.28, that is roughly $1.21. If you think that the market is fully incorporating Arrowhead Pharma's daily price movement you should consider acquiring Arrowhead Pharma options at the current volatility level of 58.16%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Arrowhead Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Arrowhead Pharma in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
29.9548.0451.75
Details
Naive
Forecast
LowNext ValueHigh
28.6832.3836.09
Details
7 Analysts
Consensus
LowTarget PriceHigh
45.0089.50106.00
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
32.4436.4140.38
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Arrowhead Pharma. Your research has to be compared to or analyzed against Arrowhead Pharma's peers to derive any actionable benefits. When done correctly, Arrowhead Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Arrowhead Pharma.

Arrowhead Pharma After-Hype Price Prediction Density Analysis

As far as predicting the price of Arrowhead Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Arrowhead Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Arrowhead Pharma, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Arrowhead Pharma Estimiated After-Hype Price Volatility

In the context of predicting Arrowhead Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Arrowhead Pharma's historical news coverage. Arrowhead Pharma's after-hype downside and upside margins for the prediction period are 29.53 and 36.95, respectively. We have considered Arrowhead Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 33.28
33.24
After-hype Price
36.95
Upside
Arrowhead Pharma is very steady asset. Analysis and calculation of next after-hype price of Arrowhead Pharma is based on 3 months time horizon.

Arrowhead Pharma Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Arrowhead Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Arrowhead Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Arrowhead Pharma, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.20  3.56   0.14   0.22  6 Events / Month5 Events / MonthIn about 6 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
33.2833.240.12 
494.44  

Arrowhead Pharma Hype Timeline

Arrowhead Pharma is presently traded for 33.28. The entity has historical hype elasticity of -0.14 and average elasticity to hype of competition of 0.22. Arrowhead is anticipated to decline in value after the next headline with the price expected to drop to 33.24. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next newsis expected to be -0.12% whereas the daily expected return is presently at -0.2%. The volatility of related hype on Arrowhead Pharma is about 324.13% with expected price after next announcement by competition of 33.5. About 70.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings (P/E) ratio of 482.39. Arrowhead Pharma recorded a loss per share of 1.08. The entity last dividend was issued on the 29th of October 2010. The firm had 1:10 split on the 17th of November 2011. Given the investment horizon of 90 days the next anticipated press release will be in about 6 days.
Please continue to Arrowhead Pharma Basic Forecasting Models to cross-verify your projections.

Arrowhead Pharma Related Hype Analysis

Having access to credible news sources related to Arrowhead Pharma's direct competition is more important than ever and may enhance your ability to predict Arrowhead Pharma's future price movements. Getting to know how Arrowhead Pharma rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Arrowhead Pharma may potentially react to the hype associated with one of its peers.

Arrowhead Pharma Additional Predictive Modules

Most predictive techniques to examine Arrowhead price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Arrowhead using various technical indicators. When you analyze Arrowhead charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Arrowhead Pharma Predictive Indicators

The successful prediction of Arrowhead Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Arrowhead Pharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Arrowhead Pharma based on analysis of Arrowhead Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Arrowhead Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Arrowhead Pharma's related companies.

Story Coverage note for Arrowhead Pharma

The number of cover stories for Arrowhead Pharma depends on current market conditions and Arrowhead Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Arrowhead Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Arrowhead Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Arrowhead Pharma Short Properties

Arrowhead Pharma's future price predictability will typically decrease when Arrowhead Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Arrowhead Pharma often depends not only on the future outlook of the potential Arrowhead Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Arrowhead Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out3.95%
Short Percent Of Float4.61%
Float Shares103.03M
Average Daily Volume Last 10 Day919.69k
Shares Short Prior Month4.83M
Average Daily Volume In Three Month763.68k
Date Short Interest31st of August 2022
Please continue to Arrowhead Pharma Basic Forecasting Models to cross-verify your projections. You can also try ETF Directory module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for analysis

When running Arrowhead Pharma price analysis, check to measure Arrowhead Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharma is operating at the current time. Most of Arrowhead Pharma's value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Arrowhead Pharma's price. Additionally, you may evaluate how the addition of Arrowhead Pharma to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Is Arrowhead Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arrowhead Pharma. If investors know Arrowhead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arrowhead Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Arrowhead Pharma is measured differently than its book value, which is the value of Arrowhead that is recorded on the company's balance sheet. Investors also form their own opinion of Arrowhead Pharma's value that differs from its market value or its book value, called intrinsic value, which is Arrowhead Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arrowhead Pharma's market value can be influenced by many factors that don't directly affect Arrowhead Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arrowhead Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Arrowhead Pharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arrowhead Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.